150 search results for: Pathophysiology

ERS 2025 | The Knowns and Unknowns in the COPD Landscape
Pulmonology
ERS 2025 | The Knowns and Unknowns in the COPD Landscape
expert video

Join Profs. Dave Singh and Klaus Rabe as they examine the clinical relevance of exacerbations, lung function, symptoms, quality of life, and comorbidities in COPD, as well as the evolving concept of disease stability and what that could mean for treatment planning and the future of COPD care.

View more
The Shared Path: Type 2 Inflammation As a Driver of Chronic Itch
Dermatology
The Shared Path: Type 2 Inflammation As a Driver of Chronic Itch
expert video

Professor Matthias Augustin highlights the role of type 2 inflammation in chronic itch across distinct pruritic skin diseases and the cumulative burden of chronic itch and skin lesions in PN.

View more
Expert Interview: Featuring Dr Shawn Kwatra on PN itch and impact on patients
Dermatology
Expert Interview: Featuring Dr Shawn Kwatra on PN itch and impact on patients
expert video

Join Dr Kwatra as he dives deeper into the mechanism of lesion formation in Prurigo Nodularis and the impact the development of these skin lesions have on patient life.

View more
Type 2 Inflammation Contributes to Itch and Fibrois in PN
Dermatology
Type 2 Inflammation Contributes to Itch and Fibrois in PN
expert video

Join Dr. Kwatra outlining the micro itch cycle involving type 2 cell polarization and cytokines that directly affect fibroblasts to cause more immune dysregulation in PN.

View more
Managing the Risk of Fibrostenosis in EoE
Gastroenterology
Managing the Risk of Fibrostenosis in EoE
expert video

Hear from Drs. Jason Lee, Kathryn Peterson, Seema Aceves, and Ikuo Hirano on disease progression and the importance of managing fibrostenotic risk in EoE.

View more
EoE Quest: Navigating the Patient Experience
Gastroenterology
EoE Quest: Navigating the Patient Experience
interactivity

Want to test your EoE knowledge while learning more about the patient journey? Try EoE Quest, an engaging and educational interactive experience.

View more
Atopic Dermatitis: Pathomechanisms: Clarifying Perspectives and Misconceptions
Dermatology
Atopic Dermatitis: Pathomechanisms: Clarifying Perspectives and Misconceptions
expert video

Join Lisa Swanson, MD, and Gina Mangin, MPAS, PA-C, for an in-depth discussion on the immunopathogenesis of atopic dermatitis (AD), highlighting the central role of key type 2 inflammatory pathways in disease development and progression. This program explores how these pathways contribute to clinical manifestations across the AD spectrum and addresses common perceptions and misconceptions surrounding AD pathomechanisms, offering clarifying insights to support informed clinical decision-making.

View more
Type 2 Inflammation
Dermatology
Type 2 Inflammation
expert video

In this video from the 2024 Society for Pediatric Dermatology Symposium held in Toronto, Canada, Dr. Peter Lio, MD and Dr. Amy Paller, MD discusses the multifaceted nature of atopic diseases, including environmental triggers, key Type 2 inflammatory mechanisms, and associated health risks, to understand the importance of early intervention in managing and potentially modifying disease progression.

View more
EADV 2025
On Demand
The Burden of a Lifetime: Can Disease Modification Rewrite the Narrative of Atopic Dermatitis?

Join Professors Jean-David Bouaziz, Amy Paller, and Alan Irvine for a dynamic presentation on the multifaceted burden of atopic dermatitis, the evolving concept of disease modification, and how targeted systemic therapies may help improve long-term patient outcomes.

ERS 2025 Enduring Video: Type 2 Severe Asthma “Unplugged”: Reducing Mucus to Improve Long- Term Patient Outcomes
On Demand
ERS 2025 Enduring Video: Type 2 Severe Asthma “Unplugged”: Reducing Mucus to Improve Long- Term Patient Outcomes

Join Drs. Njira Lugogo, Simon Couillard, and Mario Castro for a session exploring the link between pathogenic mucus and impaired lung function in patients with moderate-to-severe asthma and the potential for disease modification with targeted therapy.

EADV 2025
On Demand
Bullous Pemphigoid: Insights and Innovations

Experience this engaging presentation by Dr. Donna Culton, Prof. Dédée Murrell, and Prof. Ulrike Raap, who highlight the heterogeneous clinical presentations of BP and its burden, delve beneath the surface into how autoimmunity and predominantly type 2 inflammation mediate the disease, and explore the evolving toolbox of current approaches in BP management.